The Leukemia & Lymphoma Society (LLS) sponsors a range of programs of interest to patients and caregivers, and healthcare professionals. Recieve more information and dates of upcoming program in your area by completing our Professional Education Online Form below.
Continuing Education Information
- Nurses
Approval for nurses has been obtained by the National Office of The Leukemia & Lymphoma Society's under provider number CEP 5832 to award 2.0 continuing education contact hours through the California Board of Registered Nursing.
- Social Workers
The Leukemia & Lymphoma Society (LLS), provider number 1105, is approved as a provider for social work continuing education by the Association of Social Work Boards (ASWB) www.aswb.org Approved Continuing Education Program (ACE). Approval Period: 12/2008-12/2011. LLS maintains responsibility for the program. Social workers should contact their regulatory board to determine course approval. Social workers will receive 2.0 CE (1.75 clinical and .25 social work ethics) clock hours.
Upon completion of this program and submission of the activity evalutation, a certificate of completion will be issued to you following the program. via e-mail within 30 days. via US mail within 30 days.
Professional Educational Programs
Welcome Back: Facilitating the School Experience for Childhood Cancer Survivors
Goal: To educate school personnel and parents on the cognitive and late effects of childhood cancer treatment to improve the transition of childhood cancer survivors from clinic to classroom.
Educational Learning Objectives: At the conclusion of this program participants will be able to:
- Describe common childhood cancers and treatments
- Identify challenges for survivors: returning to school, throughout their education, and into young adulthood
- Explain laws that protect childhood cancer survivors' rights
- Implement strategies to help meet students' short- and long-term educational needs
- Access resources that support schools and families, including those from The Leukemia & Lymphoma Society
Pre-registration for this free program is required. To pre-register, please fill out the form at the bottom of this page.
Getting the Best Cancer Care at Age 55 and Older
Goal: To educate oncology nurses and social workers on current treatment strategies and assessments being utilized to improve the treatment outcomes and quality of life of older adults living with cancer.
Objectives: At the conclusion of this program, participants should be able to:
- Describe assessments used to determine appropriate cancer treatment plans for older adults
- List coping and communication strategies for older adult cancer patients and their caregivers
- Explain strategies for older adults to advocate for their best possible cancer treatments
- Describe clinical trial options for older adults with a blood cancer
Pre-registration for this free program is required. To pre-register, please fill out the form at the bottom of this page.
Living with Myeloma: An Overview of Diagnosis and Treatment
Goal: To educate oncology nurses and social workers on the current and emerging therapies in the treatment of myeloma.
Objectives: At the conclusion of this program, participants should be able to:
- Describe diagnosis and current treatment options for individuals living with myeloma
- Describe side effects and symptom management for myeloma
- Identify emerging therapies under study for myeloma
- Explain the role of stem cell transplantation in myeloma treatment
- Apply strategies to enhance quality of life for individuals living with myeloma
Pre-registration for this free program is required. To pre-register, please fill out the form at the bottom of this page.
Supported by grants from Celgene Corporation and Millennium Pharmaceuticals, Inc.
New Directions for Blood Cancer Therapies
Goal: To educate oncology nurses and social workers about the role of clinical trials in cancer treatment and how to communicate options to patients and caregivers.
Objectives: At the conclusion of this program, participants should be able to:
- Describe how new cancer treatments are developed and approved
- Distinguish between myths and facts about clinical trials
- Identify the benefits and risks of clinical trial participation
- Explain how to search for clinical trial listings for blood cancers
Pre-registration for this free program is required. To pre-register, please fill out the form at the bottom of this page.
Supported by grants from Millennium Pharmaceuticals, Inc. and Bristol-Myers Squibb
Request More Information
print page
email page
